Cortexyme announces q1 loss per share of $0.61

Cortexyme announces first quarter 2020 financial results and provides business update.q1 loss per share $0.61.q1 earnings per share estimate $-0.44 -- refinitiv ibes data.interim analysis for gain trial on track for q4 2020, with top-line results from study's final analysis expected in q4 2021.cash, cash equivalents, and short and long-term marketable securities as of march 31, were $223.5 million.
QNCX Ratings Summary
QNCX Quant Ranking